ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
13/05/2026
Voltar para busca
Dado oficial do USPTO
PARSORTIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PARSORTIX
ST13
US500000087140221Classe
1, 5, 9, 10
Pedido
87140221
Registro
5425872
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
14/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
16/08/2016
Data de registro
20/03/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/03/2025
Última transação
14/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
704
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
11
Localização do titular
GUILDFORD, GB
Examinador
LEE, IN PYO
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
CELLBXHEALTH EUROPE LIMITED
Angle Europe Limited
Representantes
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; reagents for in vitro use for scientific or medical research; buffer solutions and reagents for use in diagnostic analysis and research with laboratory apparatusseparation apparatus and analysis apparatus; biomarkersnucleic acidprotein and other biochemical ligands for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical laboratory use
Classe 5
Medical diagnostic reagents and assay components for testing of body fluids including blood and plasmacells; medical diagnostic kits comprised of diagnostic reagents and assay components for testing of body fluids including blood and plasmacells for medical purposes; all the aforesaid goods not including any such goods that are prescription only pharmaceuticals; biomarkersdiagnostic biomarker reagents for medical purposes; diagnostic reagent kits consisting primarily of medical diagnostic reagents and assaysfor use in detecting cancerous conditions and other conditions involving somatic genetic changes; medical testing kits comprising reagents to assay biochemicals including nucleic acids and proteinsfor use in detecting cancerous conditions and other conditions involving somatic genetic changes for medical purposes
Classe 9
Apparatusequipment and instruments for scientificlaboratorydiagnostic or general research uselaboratory vesselsanalyzerspre-packed columns for use in separation and purificationglasswaretubes including sample tubesreagent tubes; phlebotomy tubes and eppendorf tubes; apparatusequipment and instruments for cytologyhistology and for use in detecting cancerous conditions for laboratory or research use; apparatus in the nature of cassettes for use in laboratorydiagnostic or general research use; cell analyzer providing quantitative cell analysis for scientificlaboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analyzing blood and blood cells for laboratory or research use; biological analysis computer software; parts and fitting for the aforesaid goods; medical laboratory research instruments for use in the detection of cancer
Classe 10
Medical diagnostic apparatusequipment and instruments for diagnosis of clinical conditions involving the presence of solid tissue cells in blood; medical testing apparatusequipment and instrumentsmedical diagnostic apparatus for testing body fluids including blood and plasmacancer cells; fetal cells; parts and fittings for the aforesaid goods; diagnostic apparatusequipment and instruments for cytology and histologyall for use in detecting cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
28/03/2025
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
28/03/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/03/2025
ES8R
TEAS SECTION 8 RECEIVED
22/08/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
20/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
20/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/01/2018
PUBO
PUBLISHED FOR OPPOSITION
02/01/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/12/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/11/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
21/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
21/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/11/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
14/11/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/11/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
26/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/10/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
16/10/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/10/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
16/10/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/10/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/10/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
26/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
11/09/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/09/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
11/09/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/08/2017
ALIE
ASSIGNED TO LIE
22/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/08/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/03/2017
GNRT
NON-FINAL ACTION E-MAILED
07/03/2017
CNRT
NON-FINAL ACTION WRITTEN
07/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/02/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/12/2016
GNRT
NON-FINAL ACTION E-MAILED
06/12/2016
CNRT
NON-FINAL ACTION WRITTEN
06/12/2016
DOCK
ASSIGNED TO EXAMINER
28/11/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/08/2016
NWAP
NEW APPLICATION ENTERED
19/08/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PARSORTIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.